CCNG2 and ovarian cancer: Accordingly, we used bioinformatics to detect the downstream target genes of miR-1246 in ovarian cancer, which showed that miR-1246 inhibited cyclin G2 CCNG2 expression by interacting with a binding site on the target molecule.